(Q67725486)
Statements
A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure (English)
S D Katz
S H Kubo
S Brozena
J M Troha
J Wahl
J N Cohn
E H Sonnenblick
T H LeJemtel
1 January 1992